LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Listă Acțiuni・Stryker Corp

Stryker Corp

Închisă

SectorSănătate

316.09 0.8

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

315.23

Maxim

317.64

Indicatori cheie
By Trading Economics
Venit	-104M 745M
Vânzări	-1.2B 6B
P/E Medie Sector	36.252 49.701
EPS	1.93
Randament dividend	1.12
Marjă de profit	12.375
Angajați	56,000
EBITDA	-478M 1.2B

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+23.76% upside

Dividende
By Dow Jones
Randament dividend Medie Sector	1.12% 2.39%
Următoarele câștiguri	30 iul. 2026
Data viitoare de dividende	30 iul. 2026
Următoarea dată ex-dividende	29 iun. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-5.9B 120B
Deschiderea anterioară	315.29
Închiderea anterioară	316.09

Sentimentul știrilor

By Acuity

54%

46%

279 / 345 Clasament în Healthcare

Stryker Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 apr. 2026, 20:41 UTC

Câștiguri

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12 mar. 2026, 21:42 UTC

Evenimente importante

Stryker Says Cyberattack Disruption Is Continuing

11 mar. 2026, 19:18 UTC

Principalele dinamici ale pieței

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29 ian. 2026, 22:05 UTC

Câștiguri

Stryker Logs Higher 4Q Profit On Sales Gains

30 oct. 2025, 20:36 UTC

Câștiguri

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30 apr. 2026, 20:06 UTC

Câștiguri

Stryker 1Q Organic Net Sales Up 2.4%

30 apr. 2026, 20:06 UTC

Câștiguri

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q Adj EPS $2.60 >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q EPS $1.93 >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q Net $745M >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q Sales $6.02B >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q Net $745M >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q Adj EPS $2.60 >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q EPS $1.93 >SYK

30 apr. 2026, 20:05 UTC

Câștiguri

Stryker 1Q Sales $6B >SYK

9 apr. 2026, 20:55 UTC

Câștiguri

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 apr. 2026, 20:55 UTC

Câștiguri

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 apr. 2026, 20:55 UTC

Câștiguri

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16 mar. 2026, 00:00 UTC

Evenimente importante

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30 ian. 2026, 17:03 UTC

Market Talk

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 ian. 2026, 21:07 UTC

Câștiguri

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 ian. 2026, 21:05 UTC

Câștiguri

Stryker 4Q Adj EPS $4.47 >SYK

5 nov. 2025, 19:38 UTC

Câștiguri

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov. 2025, 17:00 UTC

Câștiguri

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 oct. 2025, 20:21 UTC

Câștiguri

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 oct. 2025, 20:05 UTC

Câștiguri

Stryker 3Q Adj EPS $3.19 >SYK

30 oct. 2025, 20:05 UTC

Câștiguri

Stryker 3Q EPS $2.22 >SYK

30 oct. 2025, 20:05 UTC

Câștiguri

Stryker 3Q Sales $6.1B >SYK

30 oct. 2025, 20:05 UTC

Câștiguri

Stryker 3Q Net $859M >SYK

Comparație

Modificare preț

Stryker Corp Așteptări

Obiectiv de preț

By TipRanks

23.76% sus

Prognoză pe 12 luni

Medie 391.67 USD 23.76%

Maxim 465 USD

Minim 315 USD

În baza a 23 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruStryker Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

23 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 23 analiști care au acordat evaluări ale acțiunilor Stryker Corp - Dist în ultimele 3 luni.

Sentiment

By Acuity

279 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.